Transverse Abdominal Plane Block for Caesarean

September 3, 2023 updated by: Ismael Guibla, Université NAZI BONI

Efficacy of Transverse Abdominal Plane Block (TAP Block) With Bupivacaine and Dexamethasone for the Management of Post-cesarean Pain at the CHU Sourô Sanou (CHUSS) in Bobo-Dioulasso

Cesarean sectionis a commonly performed major surgical procedure that results in significant postoperative pain. The objective of this study was to evaluate the effectiveness in the management of post-cesarean pain at the CHU Souro Sanou of Bobo-Dioulasso

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Houet
      • Bobo-Dioulasso, Houet, Burkina Faso
        • CHU Souro Sanou

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult parturients (≥ 18 years old) awaiting caesarean section under spinal anesthesia
  • ASAI, ASAII

Exclusion Criteria:

  • Lack of informed consent,
  • Parturients with cognitive disorders,
  • Parturients with notion of chronic pain,
  • Allergy to local anesthetics,
  • Morphine allergy
  • Parturients not understanding pain assessment scores

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: group 1
will receive at induction of spinal anesthesia 100 µg of morphine
Experimental: group 2
No morphine in spinal anesthesia but will receive a bilateral TAP block with 20 ml of Bupivacaine 0.25% and dexamethasone 4 mg in the same syringe on each side
TAP block under ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of mild pain on mobilization in the first 24 postoperative hours
Time Frame: Hours 24 postoperative
The numerical pain score after moving from a lying position to a sitting position
Hours 24 postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of mild pain at rest in the first 24 postoperative hours
Time Frame: Hours 24 postoperative
The numerical pain score at rest
Hours 24 postoperative
Proportion of mild pain on mobilization in the first 48 postoperative hours
Time Frame: Hours 48 postoperative
The numerical pain score after moving from a lying position to a sitting position
Hours 48 postoperative
Proportion of nausea-vomiting postoperative during the first 48 hours
Time Frame: Hours 48 postoperative
At each passage of the nurses
Hours 48 postoperative
Proportion of maternal satisfaction during the first 48 hours postoperatively
Time Frame: Hours 48 postoperative
The simple numerical score
Hours 48 postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2022

Primary Completion (Actual)

January 20, 2023

Study Completion (Actual)

February 20, 2023

Study Registration Dates

First Submitted

October 16, 2022

First Submitted That Met QC Criteria

October 18, 2022

First Posted (Actual)

October 20, 2022

Study Record Updates

Last Update Posted (Actual)

September 7, 2023

Last Update Submitted That Met QC Criteria

September 3, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • INSSA 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Section; Pain

Clinical Trials on TAP block

Subscribe